PTTG1 Levels Are Predictive of Saracatinib Sensitivity in Ovarian Cancer Cell Lines. [electronic resource]
Producer: 20171204Description: 293-301 p. digitalISSN:- 1752-8062
- Benzodioxoles -- pharmacology
- Cell Line, Tumor
- Cell Proliferation -- drug effects
- Down-Regulation -- drug effects
- Drug Resistance, Neoplasm -- drug effects
- Female
- Fibroblast Growth Factor 2 -- metabolism
- Gene Expression Profiling
- Gene Expression Regulation, Neoplastic -- drug effects
- Gene Knockdown Techniques
- Gene Silencing -- drug effects
- Humans
- Models, Biological
- Ovarian Neoplasms -- drug therapy
- Phosphorylation -- drug effects
- Quinazolines -- pharmacology
- RNA, Messenger -- genetics
- RNA, Small Interfering -- metabolism
- Reproducibility of Results
- Securin -- genetics
- src-Family Kinases -- metabolism
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.